Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01475 (long intergenic non-protein coding RNA 1475) is a long non-coding RNA gene located in the human genome. LincRNAs, such as LINC01475, are characterized by being autonomously transcribed RNAs longer than 200 nucleotides and situated in regions that do not overlap with annotated protein-coding genes[3][5]. These molecules typically function in gene expression regulation, including chromatin and genome architecture remodeling, transcriptional control, and fine-tuning of neighboring gene activity[3]. LincRNAs may exert their effects by acting as signals, decoys, guides, or scaffolds for ribonucleoprotein complexes and regulatory proteins[2][3]. Emerging research suggests many lincRNAs possess tissue-specific roles and may be involved in pathways leading to cancer or other diseases[3][7]. However, there is currently no evidence indicating that LINC01475 itself is a direct therapeutic target or that specific drugs interact with this RNA locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1475 (LINC01475).